More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

The latest news from AAD 2025 focused on psoriasis including abstracts, features, and helpful conference information.

Positive results were reported for Johnson & Johnson's psoriasis drug during.a late-breaking research session today at the ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Opens in a new tab or window Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of ...

Opens in a new tab or window Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed ...

However, unlike other areas, homeopathy breathes fresh air and provides acne treatment, eczema and psoriasis in a holistic way. Homeopathy is distinguished from the general treatment of the skin ...

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) ...

A study finds that 99% of dietary advice for psoriasis on Instagram is low-quality, often unsubstantiated and posted by ...

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic ...

A 27.6% increase occurred in the global incidence of pediatric psoriasis, with the largest increases among areas of lower sociodemographic indexes.

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...